Johnson & Johnson Settles Opioid Suit With Two Ohio Counties
WEDNESDAY, Oct. 2, 2019 -- With a federal trial pending, the pharmaceutical giant Johnson & Johnson agreed Wednesday to pay two Ohio counties more than $20 million for its role in the ongoing opioid crisis.
The settlement comes on the heels of a $572 million settlement the company was ordered to pay New Brunswick, New Jersey, for marketing opioids in the state, the Associated Press reported.
In the Ohio settlement, Johnson & Johnson's subsidiary Janssen Pharmaceutical agrees to pay Cuyahoga and Summit counties $10 million without admitting liability. The settlement also calls for the company to pay $5 million in legal expenses and give $5.4 million to nonprofits that fight the epidemic in northeastern Ohio, the AP reported.
Drug makers Endo, Allergan, and Mallinckrodt have also settled with these Ohio counties. Purdue Pharma has made a preliminary settlement to cover all its lawsuits, but half the states involved say they will oppose the settlement in bankruptcy court.
© 2020 HealthDay. All rights reserved.
Posted: October 2019
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.